SALT LAKE CITY , February 8, 2012 /PRNewswire/ -- Vital Access Corporation today announced that its Venous Window™ Needle Guide has been granted CE Mark clearance for use in Europe to provide vascular access for hemodialysis treatment, the most common treatment method for patients with advanced kidney failure. As a result of CE Mark clearance, Vital Access™ has begun initial efforts to ramp-up sales and marketing in Europe for its Venous Window Needle Guide. "This is a major milestone… [ more ]